Beta2-microglobulin predicts survival in primary systemic amyloidosis

This publication has 30 references indexed in Scilit:

• Value of beta 2-microglobulin level and plasma cell labeling indices as prognostic factors in patients with newly diagnosed myeloma
  Blood, 1988
• Serum Neopterin and β₂‐Microglobulin Concentrations in Monoclonal Gammopathies
  Acta Medica Scandinavica, 1988
• Serum ß2-Microglobulin lin Patients with Monoclonal Gammopathies
  The International Journal of Biological Markers, 1987
• Pretreatment serum β₂‐microglobulin in multiple myeloma
  British Journal of Haematology, 1986
• Beta₂ microglobulin in multiple myeloma
  American Journal of Hematology, 1985
• The prognostic value of serum β 2 microglobulin compared with other presentation features in myelomatosis
  British Journal of Cancer, 1985
• Beta-2-microglobulin in myeloma: optimal use for staging, prognosis, and treatment--a prospective study of 160 patients
  Blood, 1984
• Serum beta₂microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.
  British Journal of Haematology, 1983
• Prognostic significance of pretreatment serum β2-microglobulin levels in multiple myeloma
  European Journal of Cancer and Clinical Oncology, 1983
• Isolation and Properties of a Low Molecular Weight β2-Globulin Occurring in Human Biological Fluids
  Published by Elsevier ,1968